Approval · Notice of Compliance 11601 · 2010
ADVICOR: Notice of Compliance 11601
Issued July 19, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11601
- Date
- July 19, 2010
- Company
- Sepracor Pharmaceuticals IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Lipid metabolism regulator
Products in this notice
Medicinal ingredients
- NICOTINIC ACID 500 MG per TAB
- LOVASTATIN 20 MG per TAB
- NICOTINIC ACID 750 MG per TAB
- NICOTINIC ACID 1,000 MG per TAB
- LOVASTATIN 40 MG per TAB